fibrinogen has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Andrés Frutos, CD; Hidalgo de la Cruz, M; Martínez Ginés, ML; Miranda Acuña, J; Ros, AL; Tapia, SP | 1 |
| Adams, RA; Akassoglou, K; Bauer, J; Degen, JL; Flick, MJ; Lassmann, H; Nuriel, T; Sikorski, SL | 1 |
2 other study(ies) available for fibrinogen and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse.
Topics: Adult; Biomarkers; Brain; Female; Fibrinogen; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Recurrence; Sensitivity and Specificity; Spinal Cord | 2017 |
The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease.
Topics: Amino Acid Sequence; Animals; Cells, Cultured; Female; Fibrin; Fibrinogen; Macrophage-1 Antigen; Mice; Mice, Inbred C57BL; Microglia; Molecular Sequence Data; Multiple Sclerosis, Relapsing-Remitting; Peptide Fragments | 2007 |